These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12475776)

  • 21. A conserved inhibitory and differential stimulatory action of nucleotides on K(IR)6.0/SUR complexes is essential for excitation-metabolism coupling by K(ATP) channels.
    Babenko AP; Bryan J
    J Biol Chem; 2001 Dec; 276(52):49083-92. PubMed ID: 11673467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose.
    Ritzel RA; Hansen JB; Veldhuis JD; Butler PC
    J Clin Endocrinol Metab; 2004 Feb; 89(2):795-805. PubMed ID: 14764798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATP sensitivity of the ATP-sensitive K+ channel in intact and permeabilized pancreatic beta-cells.
    Tarasov AI; Girard CA; Ashcroft FM
    Diabetes; 2006 Sep; 55(9):2446-54. PubMed ID: 16936192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single nucleotide polymorphisms in K(ATP) channels: muscular impact on type 2 diabetes.
    Li L; Shi Y; Wang X; Shi W; Jiang C
    Diabetes; 2005 May; 54(5):1592-7. PubMed ID: 15855351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation.
    Béguin P; Nagashima K; Nishimura M; Gonoi T; Seino S
    EMBO J; 1999 Sep; 18(17):4722-32. PubMed ID: 10469651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of the insulin-releasing action of alpha-ketoisocaproate and related alpha-keto acid anions.
    Heissig H; Urban KA; Hastedt K; Zünkler BJ; Panten U
    Mol Pharmacol; 2005 Oct; 68(4):1097-105. PubMed ID: 16014804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KATP channel openers: structure-activity relationships and therapeutic potential.
    Mannhold R
    Med Res Rev; 2004 Mar; 24(2):213-66. PubMed ID: 14705169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The actions of a novel potent islet beta-cell specific ATP-sensitive K+ channel opener can be modulated by syntaxin-1A acting on sulfonylurea receptor 1.
    Ng B; Kang Y; Elias CL; He Y; Xie H; Hansen JB; Wahl P; Gaisano HY
    Diabetes; 2007 Aug; 56(8):2124-34. PubMed ID: 17496234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells.
    Moritz W; Leech CA; Ferrer J; Habener JF
    Endocrinology; 2001 Jan; 142(1):129-38. PubMed ID: 11145575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP.
    Jin JY; Park SH; Bae JH; Cho HC; Lim JG; Park WS; Han J; Lee JH; Song DK
    Pharmacol Res; 2007 Sep; 56(3):237-47. PubMed ID: 17656102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ATP-sensitive K+ channel].
    Nagashima K
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():548-52. PubMed ID: 12238096
    [No Abstract]   [Full Text] [Related]  

  • 32. Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells.
    Jonas JC; Plant TD; Henquin JC
    Br J Pharmacol; 1992 Sep; 107(1):8-14. PubMed ID: 1358388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single residue (K332A) substitution in Kir6.2 abolishes the stimulatory effect of long-chain acyl-CoA esters: indications for a long-chain acyl-CoA ester binding motif.
    Bränström R; Leibiger IB; Leibiger B; Klement G; Nilsson J; Arhem P; Aspinwall CA; Corkey BE; Larsson O; Berggren PO
    Diabetologia; 2007 Aug; 50(8):1670-7. PubMed ID: 17522836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
    Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
    Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The insulin secretory granule is the major site of K(ATP) channels of the endocrine pancreas.
    Geng X; Li L; Watkins S; Robbins PD; Drain P
    Diabetes; 2003 Mar; 52(3):767-76. PubMed ID: 12606519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic regulation of the pancreatic beta-cell ATP-sensitive K+ channel: a pas de deux.
    Tarasov A; Dusonchet J; Ashcroft F
    Diabetes; 2004 Dec; 53 Suppl 3():S113-22. PubMed ID: 15561898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATP4- mediates closure of pancreatic beta-cell ATP-sensitive potassium channels by interaction with 1 of 4 identical sites.
    Markworth E; Schwanstecher C; Schwanstecher M
    Diabetes; 2000 Sep; 49(9):1413-8. PubMed ID: 10969823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variations in insulin secretion in carriers of the E23K variant in the KIR6.2 subunit of the ATP-sensitive K(+) channel in the beta-cell.
    't Hart LM; van Haeften TW; Dekker JM; Bot M; Heine RJ; Maassen JA
    Diabetes; 2002 Oct; 51(10):3135-8. PubMed ID: 12351459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PIP2 and ATP cooperatively prevent cytosolic Ca2+-induced modification of ATP-sensitive K+ channels in rat pancreatic beta-cells.
    Koriyama N; Kakei M; Nakazaki M; Yaekura K; Ichinari K; Gong Q; Morimitsu S; Yada T; Tei C
    Diabetes; 2000 Nov; 49(11):1830-9. PubMed ID: 11078449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The beta-cell glibenclamide receptor is an ADP-binding protein.
    Niki I; Nicks JL; Ashcroft SJ
    Biochem J; 1990 Jun; 268(3):713-8. PubMed ID: 2114099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.